127 related articles for article (PubMed ID: 32092260)
1. Antituberculosis Activity of the Antimalaria Cytochrome
Chong SMS; Manimekalai MSS; Sarathy JP; Williams ZC; Harold LK; Cook GM; Dick T; Pethe K; Bates RW; Grüber G
ACS Infect Dis; 2020 Apr; 6(4):725-737. PubMed ID: 32092260
[TBL] [Abstract][Full Text] [Related]
2. Targeting the menaquinol binding loop of mycobacterial cytochrome bd oxidase.
Harikishore A; Chong SSM; Ragunathan P; Bates RW; Grüber G
Mol Divers; 2021 Feb; 25(1):517-524. PubMed ID: 31939065
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of a Hybrid Respiratory Supercomplex Consisting of Mycobacterium tuberculosis Cytochrome bcc and Mycobacterium smegmatis Cytochrome aa3.
Kim MS; Jang J; Ab Rahman NB; Pethe K; Berry EA; Huang LS
J Biol Chem; 2015 Jun; 290(23):14350-60. PubMed ID: 25861988
[TBL] [Abstract][Full Text] [Related]
4. Exploiting the synthetic lethality between terminal respiratory oxidases to kill
Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330
[TBL] [Abstract][Full Text] [Related]
5. An amiloride derivative is active against the F
Hards K; Cheung CY; Waller N; Adolph C; Keighley L; Tee ZS; Harold LK; Menorca A; Bujaroski RS; Buckley BJ; Tyndall JDA; McNeil MB; Rhee KY; Opel-Reading HK; Krause K; Preiss L; Langer JD; Meier T; Hasenoehrl EJ; Berney M; Kelso MJ; Cook GM
Commun Biol; 2022 Feb; 5(1):166. PubMed ID: 35210534
[TBL] [Abstract][Full Text] [Related]
6. Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis.
Lee BS; Hards K; Engelhart CA; Hasenoehrl EJ; Kalia NP; Mackenzie JS; Sviriaeva E; Chong SMS; Manimekalai MSS; Koh VH; Chan J; Xu J; Alonso S; Miller MJ; Steyn AJC; Grüber G; Schnappinger D; Berney M; Cook GM; Moraski GC; Pethe K
EMBO Mol Med; 2021 Jan; 13(1):e13207. PubMed ID: 33283973
[TBL] [Abstract][Full Text] [Related]
7. Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome
Jeffreys LN; Ardrey A; Hafiz TA; Dyer LA; Warman AJ; Mosallam N; Nixon GL; Fisher NE; Hong WD; Leung SC; Aljayyoussi G; Bibby J; Almeida DV; Converse PJ; Fotouhi N; Berry NG; Nuermberger EL; Upton AM; O'Neill PM; Ward SA; Biagini GA
ACS Infect Dis; 2023 Feb; 9(2):221-238. PubMed ID: 36606559
[No Abstract] [Full Text] [Related]
8. Response of
Chauhan P; van der Meulen SA; Simões Caetano JM; Goojani HG; Botman D; van Spanning R; Lill H; Bald D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142240
[TBL] [Abstract][Full Text] [Related]
9. Structure of
Zhou S; Wang W; Zhou X; Zhang Y; Lai Y; Tang Y; Xu J; Li D; Lin J; Yang X; Ran T; Chen H; Guddat LW; Wang Q; Gao Y; Rao Z; Gong H
Elife; 2021 Nov; 10():. PubMed ID: 34819223
[TBL] [Abstract][Full Text] [Related]
10. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc
Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K
Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid Bactericidal Activity Involves Electron Transport Chain Perturbation.
Zeng S; Soetaert K; Ravon F; Vandeput M; Bald D; Kauffmann JM; Mathys V; Wattiez R; Fontaine V
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642937
[TBL] [Abstract][Full Text] [Related]
12. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D
Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632
[TBL] [Abstract][Full Text] [Related]
13. Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in
Sorayah R; Manimekalai MSS; Shin SJ; Koh WJ; Grüber G; Pethe K
ACS Infect Dis; 2019 Dec; 5(12):2055-2060. PubMed ID: 31599569
[No Abstract] [Full Text] [Related]
14. Targeting the cytochrome oxidases for drug development in mycobacteria.
Lee BS; Sviriaeva E; Pethe K
Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616
[TBL] [Abstract][Full Text] [Related]
15. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.
Arora K; Ochoa-Montaño B; Tsang PS; Blundell TL; Dawes SS; Mizrahi V; Bayliss T; Mackenzie CJ; Cleghorn LA; Ray PC; Wyatt PG; Uh E; Lee J; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2014 Nov; 58(11):6962-5. PubMed ID: 25155596
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria.
Lee BS; Kalia NP; Jin XEF; Hasenoehrl EJ; Berney M; Pethe K
J Biol Chem; 2019 Feb; 294(6):1936-1943. PubMed ID: 30530783
[TBL] [Abstract][Full Text] [Related]
17. Insights into the Physiology and Metabolism of a Mycobacterial Cell in an Energy-Compromised State.
Patil V; Jain V
J Bacteriol; 2019 Oct; 201(19):. PubMed ID: 31285242
[No Abstract] [Full Text] [Related]
18. Efflux Attenuates the Antibacterial Activity of Q203 in Mycobacterium tuberculosis.
Jang J; Kim R; Woo M; Jeong J; Park DE; Kim G; Delorme V
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416541
[TBL] [Abstract][Full Text] [Related]
19. Deciphering insights into the binding mechanism and plasticity of Telacebec with
Ray B; Roy KK
J Biomol Struct Dyn; 2023 Dec; ():1-14. PubMed ID: 38111165
[TBL] [Abstract][Full Text] [Related]
20. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
